Gene Page:UBE2B
概括?
基因 | 7320 |
象征 | UBE2B |
Synonyms | E2-17kDa|HHR6B|HR6B|RAD6B|UBC2 |
Description | 泛素的jugating enzyme E2 B |
Reference | MIM:179095|HGNC:HGNC:12473|Ensembl:ENSG00000119048|HPRD:01533|Vega:OTTHUMG00000129120 |
Gene type | protein-coding |
Map location | 5Q31.1 |
Pascal p-value | 0.223 |
Sherlock p-value | 0.074 |
DMG | 1 (# studies) |
eGene | Myers' cis & trans |
数据源中的基因
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DMG:Jaffe_2016 | Genome-wide DNA methylation analysis | This dataset includes 2,104 probes/CpGs associated with SZ patients (n=108) compared to 136 controls at Bonferroni-adjusted P < 0.05. | 1 |
GSMA_I | Genome scan meta-analysis | Psr: 0.0032 | |
Expression | Meta-analysis of gene expression | Pvalue: 1.559 |
第一节遗传学和表观遗传学注释
Differentially methylated gene
Probe | Chromosome | Position | Nearest gene | P (dis) | Beta (dis) | FDR (dis) | Study |
---|---|---|---|---|---|---|---|
CG00588727 | 5 | 133707840 | UBE2B | 1.31E-9 | -0.008 | 1.35E-6 | DMG:Jaffe_2016 |
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs11682393 | chr2 | 47804496 | UBE2B | 7320 | 0.08 | trans | ||
rs13125675 | chr4 | 40938622 | UBE2B | 7320 | 0.13 | trans | ||
rs2369618 | chrX | 6252204 | UBE2B | 7320 | 0.11 | trans | ||
RS10218335 | chrX | 6350730 | UBE2B | 7320 | 0.02 | trans | ||
rs16984151 | chrX | 6354595 | UBE2B | 7320 | 0.08 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/UBE2B_DE_GTEx.png)
Gene expression of temporal and spatial changes (BrainSpan)
脚注:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0005515 | protein binding | IEA | - | |
去:0004842 | ubiquitin-protein ligase activity | IEA | - | |
GO:0016874 | ligase activity | IEA | - | |
生物过程 | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0006511 | ubiquitin-dependent protein catabolic process | TAS | 1559696 | |
GO:0006301 | postreplication repair | TAS | 1559696 | |
GO:0007288 | sperm axoneme assembly | IEA | - | |
GO:0051246 | regulation of protein metabolic process | IEA | - | |
GO:0043687 | 翻译后蛋白质修饰 | IEA | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0000785 | chromatin | IEA | - | |
GO:0005634 | nucleus | IEA | - | |
GO:0005886 | plasma membrane | IEA | - |
V.途径注释
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG UBIQUITIN MEDIATED PROTEOLYSIS | 138 | 98 | 该途径中的所有SZGR 2.0基因 |
REACTOME IMMUNE SYSTEM | 933 | 616 | 该途径中的所有SZGR 2.0基因 |
REACTOME适应性免疫系统 | 539 | 350 | 该途径中的所有SZGR 2.0基因 |
REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 251 | 156 | 该途径中的所有SZGR 2.0基因 |
REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 212 | 129 | 该途径中的所有SZGR 2.0基因 |
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA UP | 1382 | 904 | 该途径中的所有SZGR 2.0基因 |
OSMAN BLADDER CANCER DN | 406 | 230 | 该途径中的所有SZGR 2.0基因 |
RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED DN | 805 | 505 | 该途径中的所有SZGR 2.0基因 |
AMUNDSON RESPONSE TO ARSENITE | 217 | 143 | 该途径中的所有SZGR 2.0基因 |
NUYTTEN EZH2 TARGETS DN | 1024 | 594 | 该途径中的所有SZGR 2.0基因 |
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP | 811 | 508 | 该途径中的所有SZGR 2.0基因 |
洛佩兹MBD目标 | 957 | 597 | 该途径中的所有SZGR 2.0基因 |
KAUFFMANN DNA REPAIR GENES | 230 | 137 | 该途径中的所有SZGR 2.0基因 |
KAUFFMANN DNA REPLICATION GENES | 147 | 87 | 该途径中的所有SZGR 2.0基因 |
OKUMURA INFLAMMATORY RESPONSE LPS | 183 | 115 | 该途径中的所有SZGR 2.0基因 |
ZHAN MULTIPLE MYELOMA CD1 AND CD2 DN | 51 | 32 | 该途径中的所有SZGR 2.0基因 |
KUMAR TARGETS OF MLL AF9 FUSION | 405 | 264 | 该途径中的所有SZGR 2.0基因 |
BLALOCK ALZHEIMERS DISEASE DN | 1237 | 837 | 该途径中的所有SZGR 2.0基因 |
WANG CISPLATIN RESPONSE AND XPC DN | 228 | 146 | 该途径中的所有SZGR 2.0基因 |
HEDENFALK BREAST CANCER BRCA1 VS BRCA2 | 163 | 113 | 该途径中的所有SZGR 2.0基因 |
由Foxp3绑定的Marson未刺激 | 1229 | 713 | 该途径中的所有SZGR 2.0基因 |
IWANAGA CARCINOGENESIS BY KRAS PTEN DN | 353 | 226 | 该途径中的所有SZGR 2.0基因 |
MITSIADES RESPONSE TO APLIDIN UP | 439 | 257 | 该途径中的所有SZGR 2.0基因 |
Bonome卵巢癌的生存次优秀 | 510 | 309 | 该途径中的所有SZGR 2.0基因 |
ZHANG BREAST CANCER PROGENITORS UP | 425 | 253 | 该途径中的所有SZGR 2.0基因 |
MATZUK SPERMATOCYTE | 72 | 55 | 该途径中的所有SZGR 2.0基因 |
MATZUK SPERMATID DIFFERENTIATION | 37 | 26 | 该途径中的所有SZGR 2.0基因 |
MOOTHA PGC | 420 | 269 | 该途径中的所有SZGR 2.0基因 |
HUNSBERGER EXERCISE REGULATED GENES | 31 | 26 | 该途径中的所有SZGR 2.0基因 |
SHAFFER IRF4 TARGETS IN MYELOMA VS MATURE B LYMPHOCYTE | 101 | 76 | 该途径中的所有SZGR 2.0基因 |
MILI PSEUDOPODIA CHEMOTAXIS DN | 457 | 302 | 该途径中的所有SZGR 2.0基因 |
米利假足型haptotaxis dn | 668 | 419 | 该途径中的所有SZGR 2.0基因 |
肌肉中的罗马胰岛素靶标 | 442 | 263 | 该途径中的所有SZGR 2.0基因 |
CHIANG LIVER CANCER SUBCLASS UNANNOTATED UP | 85 | 50 | 该途径中的所有SZGR 2.0基因 |
BROWNE HCMV INFECTION 1HR UP | 61 | 44 | 该途径中的所有SZGR 2.0基因 |
CHICAS RB1 TARGETS SENESCENT | 572 | 352 | 该途径中的所有SZGR 2.0基因 |
PILON KLF1 TARGETS DN | 1972 | 1213 | 该途径中的所有SZGR 2.0基因 |
BRUINS UVC RESPONSE LATE | 1137 | 655 | 该途径中的所有SZGR 2.0基因 |
RAO BOUND BY SALL4 ISOFORM B | 517 | 302 | 该途径中的所有SZGR 2.0基因 |
Section VI. microRNA annotation
mirna家族 | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-124.1 | 319 | 325 | m8 | hsa-miR-124a | UUAAGGCACGCGGUGAAUGCCA |
miR-124/506 | 319 | 325 | 1A | hsa-miR-506 | UAAGGCACCCUUCUGAGUAGA |
hsa-miR-124brain | UAAGGCACGCGGUGAAUGCC | ||||
miR-181 | 593 | 600 | 1A,m8 | HSA-MIR-181Abrain | aacauucaacgcugucggugagu |
HSA-MIR-181BSZ | AACAUUCAUUGCUGUCGGUGGG | ||||
HSA-MIR-181Cbrain | AACAUUCAACCUGUCGGUGAGU | ||||
HSA-MIR-181Dbrain | AACAUUCAUUGUUGUCGGUGGGUU | ||||
miR-186 | 333 | 340 | 1A,m8 | hsa-miR-186 | CAAAGAAUUCUCCUUUUGGGCUU |
miR-200bc/429 | 1092 | 1098 | m8 | HSA-MIR-200B | UAAUACUGCCUGGUAAUGAUGAC |
HSA-MIR-200C | UAAUACUGCCGGGUAAUGAUGG | ||||
hsa-miR-429 | UAAUACUGUCUGGUAAAACCGU | ||||
mir-377 | 183 | 189 | 1A | hsa-miR-377 | aucacacaaaggaacuuuuugu |
miR-410 | 375 | 381 | 1A | hsa-miR-410 | aauauaacacagauggcugu |
miR-505 | 1170 | 1176 | 1A | hsa-miR-505 | GUCAACACUUGCUGGUUUCCUC |
miR-93.hd/291-3p/294/295/302/372/373/520 | 360 | 367 | 1A,m8 | hsa-miR-93brain | AAAGUGCUGUUCGUGCAGGUAG |
hsa-miR-302a | UAAGUGCUUCCAUGUUUUGGUGA | ||||
hsa-miR-302b | UAAGUGCUUCCAUGUUUUAGUAG | ||||
hsa-miR-302c | uaagugcuuccauguucagugg | ||||
hsa-miR-302d | UAAGUGCUUCCAUGUUUGAGUGU | ||||
hsa-miR-372 | AAAGUGCUGCGACAUUUGAGCGU | ||||
hsa-miR-373 | GAAGUGCUUCGAUUUUGGGGUGU | ||||
hsa-miR-520e | Aaagugcuuuuuugaggg | ||||
hsa-miR-520a | AAAGUGCUUCCCUUUGGACUGU | ||||
hsa-miR-520b | AAAGUGCUUCCUUUUAGAGGG | ||||
hsa-miR-520c | AAAGUGCUUCCUUUUAGAGGGUU | ||||
hsa-miR-520d | AAAGUGCUUCUCUUUGGUGGGUU |